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INTRODUCTION
Carcinoid tumors comprise 1-2% of all lung tu-
mors (1). Although carcinoid tumors are generally
considered to represent a low-grade malignancy, an
atypical variant exists that exhibits more virulent
behavior and less favorable prognosis. The first de-
scription of atypical carcinoid tumor appeared in
1944, when Engelbreth-Holm described two cases
of bronchial carcinoids with atypical features (2).
Treatment for carcinoid tumors involves complete
surgical removal, while a more aggressive approach
is required in the treatment of atypical carcinoid
tumors. The case of atypical carcinoid tumor de-
scribed herein was discovered as multiple nodular
shadows and pleural effusion on chest radiography,
and was diagnosed by video-assisted thoracoscopy.
Aggravation of the condition was rapid and the pa-
tient died shortly after admission. Autopsy was per-
formed. We describe an unusual case of atypical
carcinoid tumor of the lung and review the rele-
vant literature.
CASE REPORT
An 82-year-old man was referred to our hospital
from his local physician due to dry cough, dyspnea
and abnormal chest shadows on chest radiography.
He had never smoked. On admission to our hospi-
tal, no abnormalities were identified other than
weakness of breath sounds in the left chest. Labo-
ratory blood examination revealed decreases in
both hemoglobin and total protein levels (Table 1).
Erythrocyte sedimentation rate and levels of C-
reactive protein and lactate dehydrogenase were
elevated. In addition, serum levels of neuron-specific
enolase (NSE), a tumor marker, were markedly
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increased (normal :10 ng/ml). Conversely, carci-
noembryonic antigen and progastrin-releasing pep-
tide levels were within normal ranges.
Radiography and computed tomography (CT) of
the chest reveled multiple nodules in bilateral mid-
dle and lower lobes, and bilateral pleural effusion
(Figs. 1, 2). Multiple metastases to the bone and
liver were also noted. Although bronchoscopy was
performed, a definitive diagnosis could be identi-
fied.
Specimens for histological examination were ob-
tained from the pleural wall lesion by video-assisted
thoracoscopic surgery under local anesthesia. Tho-
racoscopic findings showed multiple nodules at the
pleural surface. Histological findings demonstrated
that tumor cells displayed small, round nuclei with
increased levels of chromatin and a low nucleus/
cytoplasm (N/C) ratio. Cells displayed a nested,
nodular arrangement and numerous mitotic figures,
and intracellular connections were weak. Blood
vessels were included diffusely inside tumors and
necrotic lesions were also occasionally observed in
high-power fields (Fig. 3). Immunohistochemistry
revealed that tumor cells were positive for chromo-
granin A, NSE and synaptophysin (Fig. 4), and nega-
tive for AE 1/3, CK7, CK20, EMA, CEA and thy-
roid transcription factor (TTF)-1 (data not shown).
MIB-I index was 10%. Histological diagnosis was
Fig. 1 Chest radiography on admission showing multiple nod-
ules in both lungs.
a
b
Fig. 2 a, b) Chest CT on admission, demonstrating multiple
shadows in both lung fields.
Table 1. Clinical examination test on admission
WBC 6900/μl
Neutro 63.1%
Eos. 5.1%
Baso. 1.2%
Mono. 6.1%
Lymph. 24.5%
RBC 391104/μl
Hb 11.9g/dl
Ht 35.7%
Plt 21.1104/μl
ESR 50mm/hour
CRP 0.85mg/dl
GOT 19IU/L
GPT 22IU/L
LDH 230IU/L
T-Bil 0.46mg/dl
γ-GTP 62IU/L
TP 6.2g/dl
BUN 20.3mg/dl
Cre 0.97mg/dl
Na 141mEq/L
K 4.40mEq/L
Cl 109mEq/L
NSE 57ng/ml
Pro-GRP 17.4pg/ml
CEA 3.3ng/ml
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atypical carcinoid, not small cell carcinoma, based
on the following findings : tumor cells showed low
N/C ratio, presence of clear, big nuclei compared
with those in small cell carcinoma, positivity for
chromogranin A, and overly extensive synapto-
physin. Tendency of infiltration to organs was weak,
and cells formed clumps (Table 2). Given the ana-
tomical location of the tumor, atypical carcinoid was
diagnosed.
For control of pleural effusion, local combination
chemotherapy comprising hypotonic cisplatin treat-
ment using 250 ml distilled water, cisplatin 10 mg,
OK432 10KE, and 100 mg minocycline was initiated
according to a modification of the method described
by Ichinose, et al . (3). This treatment had no effect.
Disease progressed rapidly and the patient died on
day 17 after initiation of treatment. Autopsy was
performed, and no lesion of atypical carcinoid could
be confirmed in the digestive organs, although80%
of carcinoid tumors develop in the wall of the hol-
low organs of the gastrointestinal tract (4). The tu-
mor was thus identified as atypical carcinoid tumor
arising from the lungs.
a
b
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d
Fig. 3 a-d) The specimen obtained from the wall side of the
pleural lesion using thoracoscopy showed small nuclei and small
deep stained round nuclei with many nuclear division (b), with
weak intercellular connections but infiltrative growth with al-
veolar structures containing vessels. Several areas appeared
rosette-like (c). Necrotic areas were identified (d).
a
b
Fig. 4 a, b) Immunohistochemical findings show positive
staining of tumor cells for synaptophysin and chromogranin A.
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DISCUSSION
Carcinoid tumors constitute approximately 1-2%
of all lung tumors (5). These are low-grade malig-
nancies that belong to the amine precursor uptake
decarboxylase group of tumors. The bronchopul-
monary tract has a rich and complex complement
of neuroendocrine cells (6), and bronchial carci-
noids appear to share a common neuroectodermal
stem cell origin with small cell carcinoma of the
lung (7).
The clinical presentation of carcinoid tumors
largely depends on location and size. Tumors usually
cause symptoms only after growing large enough
to restrict the airways. Moreover, carcinoid syn-
drome appears in patients with carcinoids (7). How-
ever, the present patient showed neither signs nor
symptoms suggestive of carcinoid syndrome.
Carcinoids can be divided into typical and atypi-
cal types, the difference being first defined by the
histopathological criteria of Arrigoni, et al . and
later modified by Travis, et al ., eventually result-
ing in the generally accepted classification (8 -10).
Carcinoids are almost equally distributed between
males and females (9). Mean age of onset is ap-
proximately 47 years, but atypical carcinoid tumors
occur in significantly older patients (11-13). Al-
though this theory is speculative, such age differ-
ences might be due to smoking as a risk factor. Sev-
eral studies support the hypothesis that smoking
may represent a risk factor in the development of
atypical carcinoid tumor (14-15), but the present
patient was a non-smoker.
In accordance with the classification of typical
carcinoids and atypical carcinoids on pathological
and clinical grounds, molecular studies have also
shown differences between typical and atypical car-
cinoids and between atypical carcinoids and other
neuroendocrine tumors (16 -20). Based on these
reports, abnormalities in tumor-suppressor genes
and oncogenes are seen more frequently in atypi-
cal than in typical carcinoids.
Chest imaging is widely recognized for detecting
mean lesion sizes of approximately 3 cm (although
much larger lesions are also frequent), mostly cen-
trally located, with only approximately one-third lo-
cated in peripherally (21). In this case, chest radi-
ography showed multiple nodules in both lungs.
To the best of our knowledge, pulmonary atypical
carcinoid with multiple nodules in bilateral lung
fields on diagnosis is very rare. Metastasis was ob-
served more frequently with atypical carcinoid tu-
mors than for other bronchopulmonary carcinoids
(22). The multiple nodules in our case were con-
sidered pulmonary metastases of atypical carcinoid
tumor. Although the primary site in this case was
unclear, we did not identify atypical carcinoid cells
in the digestive organs, which are the most com-
mon primary organ after autopsy. We thus consider
that the primary organ in this case was the lungs.
In conclusion, we have presented an autopsy case
of rapid progressive atypical carcinoid of the lung
discovered as multiple nodular shadows and a rare
clinical course involving no carcinoid syndrome
signs. Furthermore, the outcome following che-
motherapeutic treatment was fatal. In this regard,
early diagnosis is important for more successful
surgical treatment.
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